Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05288699

Mobile App for Latinx Hazardous Drinkers With Clinical Anxiety

Brief Personalized Feedback Intervention for Latinx Hazardous Drinkers: A Community-Based Intervention

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
Michael J. Zvolensky, Ph.D. · Academic / Other
Sex
All
Age
21 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to develop and examine a culturally adapted, brief, integrated, Spanish language mobile health application for the Android platform, optimized to deliver a personalized feedback intervention (PFI) designed to enhance knowledge regarding adverse anxiety-alcohol interrelations, increase motivation and intention to reduce hazardous drinking, and reduce positive attitudes and intention regarding anxiety-related alcohol use among Latinx hazardous drinkers with clinical anxiety.

Detailed description

Investigators will develop a culturally adapted, brief, single-session, Spanish language, PFI delivered via a mobile health application for the Android platform through an iterative approach using expert input and focus groups. Next, Latinx hazardous drinkers with clinical anxiety will assess program navigation and conduct usability testing. Finally, Latinx hazardous drinkers with clinical anxiety will be recruited to complete the final prototype of the mobile health application in order to evaluate the feasibility, acceptability, and initial effects. Initial screening will be conducted via telephone; baseline and post-treatment data will be collected in-person; and 1-week, 1-month, and 3-months follow-up data will be collected remotely.

Conditions

Interventions

TypeNameDescription
BEHAVIORALAlientoAliento is a culturally adapted, brief, personalized feedback intervention (PFI) to address alcohol misuse in the context of clinical anxiety delivered via a mobile application.

Timeline

Start date
2022-11-04
Primary completion
2025-02-28
Completion
2025-04-30
First posted
2022-03-21
Last updated
2024-05-14

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05288699. Inclusion in this directory is not an endorsement.